best performing mid cap stock february 2012 to march 2012

TG Therapeutics (TGTX) had the highest return between February 1, 2012 and March 31, 2012 by a mid-cap US stock, returning 166.7%.

ASSET DATE % RETURN
TG Therapeutics (TGTX)
2/1/2012 - 3/31/2012
166.66%
Patrick Industries (PATK)
2/1/2012 - 3/31/2012
109.12%
Caesars Entertainment (CZR)
2/1/2012 - 3/31/2012
100.41%
Sarepta Therapeutics (SRPT)
2/1/2012 - 3/31/2012
70.37%
IES (IESC)
2/1/2012 - 3/31/2012
59.62%
Radian (RDN)
2/1/2012 - 3/31/2012
56.57%
ASGN (ASGN)
2/1/2012 - 3/31/2012
54.19%
Applied Digital (APLD)
2/1/2012 - 3/31/2012
53.85%
Capri (CPRI)
2/1/2012 - 3/31/2012
50.29%
Frontline (FRO)
2/1/2012 - 3/31/2012
49.61%
EPAM Systems (EPAM)
2/1/2012 - 3/31/2012
49.24%
Repligen (RGEN)
2/1/2012 - 3/31/2012
46.04%
Dillard's (DDS)
2/1/2012 - 3/31/2012
42.31%
Archrock (AROC)
2/1/2012 - 3/31/2012
40.77%
ACADIA Pharmaceuticals (ACAD)
2/1/2012 - 3/31/2012
39.61%
Pilgrims Pride (PPC)
2/1/2012 - 3/31/2012
37.64%
Marriot Vacations Worldwide (VAC)
2/1/2012 - 3/31/2012
37.46%
Gap (GAP)
2/1/2012 - 3/31/2012
36.86%
Arrowhead Pharmaceuticals (ARWR)
2/1/2012 - 3/31/2012
35.17%
Prestige Brand (PBH)
2/1/2012 - 3/31/2012
34.77%
Addus HomeCare (ADUS)
2/1/2012 - 3/31/2012
34.15%
HCI (HCI)
2/1/2012 - 3/31/2012
33.58%
Pegasystems (PEGA)
2/1/2012 - 3/31/2012
33.25%
Alphatec (ATEC)
2/1/2012 - 3/31/2012
33.15%
Acadia Healthcare (ACHC)
2/1/2012 - 3/31/2012
33.06%
Mid-cap stocks are treated as having a market cap between $2B and $10B.